tiprankstipranks
Siemens Healthineers Reports Robust Q1 2025 Performance
Company Announcements

Siemens Healthineers Reports Robust Q1 2025 Performance

Siemens Healthineers ( (SEMHF) ) has released its Q1 earnings. Here is a breakdown of the information Siemens Healthineers presented to its investors.

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

Siemens Healthineers AG is a leading medtech company specializing in medical imaging, laboratory diagnostics, point-of-care testing, and healthcare IT, with a strong focus on innovation and technological advancement in the healthcare sector.

Siemens Healthineers has reported a solid start to its fiscal year 2025, showcasing strong financial results for the first quarter. The company’s revenue grew by 5.7% on a comparable basis, reaching nearly €5.5 billion, with significant contributions from its Imaging and Varian segments.

The company’s key financial metrics for the quarter include an excellent equipment book-to-bill ratio of 1.21 and an overall adjusted EBIT margin of 15.0%, surpassing the prior-year quarter. Notably, free cash flow surged to approximately €810 million, more than tripling from the previous year. The Imaging segment posted a 7.6% revenue growth, while the Diagnostics segment saw a 1.6% increase, supported by cost reductions from its transformation program.

Siemens Healthineers’ performance in the Americas and Asia Pacific Japan regions was particularly strong, while the China region faced challenges due to order delays. The company’s focus on revenue growth and strategic cost management has positively influenced its financial outcomes, as reflected in a net income increase of 11% to €478 million.

Looking ahead, Siemens Healthineers maintains its outlook for fiscal year 2025, anticipating comparable revenue growth of 5% to 6%. The company expects adjusted basic earnings per share to range between €2.35 and €2.50, emphasizing a stable macroeconomic environment and favorable currency effects as contributing factors to its forecast.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App